Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese

BACKGROUND: Whether rosiglitazone may affect the risk of non-melanoma skin cancer (NMSC) has not been investigated. METHODS: The reimbursement databases of all Taiwanese diabetic patients from 1996 to 2009 were retrieved from the National Health Insurance. An entry date was set at 1 January 2006 and...

Descripción completa

Detalles Bibliográficos
Autor principal: Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325941/
https://www.ncbi.nlm.nih.gov/pubmed/25655946
http://dx.doi.org/10.1186/s12885-015-1057-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325941/
https://www.ncbi.nlm.nih.gov/pubmed/25655946
http://dx.doi.org/10.1186/s12885-015-1057-8

Ejemplares similares